After lunch, your favorite jeans suddenly feel two sizes smaller, and the pressure under your ribs will not quit until evening. Bloating is one of the most common digestive complaints in the world, affecting up to 30 percent of adults regularly and over 90 percent of people with IBS. So it is no surprise that "best probiotic for bloating" is one of the most-Googled supplement questions in the United States. The honest answer is that no single strain is best, but a small set has real, published clinical data, and a clear pattern about who benefits, how much to take, and how long to give it.
What Causes Bloating, and Why Probiotics Sometimes Help
Bloating has several distinct causes, and probiotics only address some. Excess gas production: gut bacteria ferment fiber and undigested carbs, releasing hydrogen, methane, and carbon dioxide; in dysbiosis or with a high-FODMAP diet, fermentation runs too hot. Visceral hypersensitivity: many IBS patients have normal gas amounts but perceive normal distension as painful because the gut-brain axis amplifies routine signals. Impaired gas transit: when motility is sluggish, gas pools in specific segments. Constipation: slower stool transit means more fermentation time and more retained gas. For each, the right probiotic strain can help, but only if it matches.
The strain-specificity rule that matters most
Probiotics are not interchangeable. The 2024 ESNM/UEG European consensus on functional bloating emphasized that results from one strain cannot be extrapolated to another, even within the same species. NCCIH makes the same point: if one Lactobacillus helps prevent a condition, that does not mean another Lactobacillus or any Bifidobacterium will. Strain identity, dose, and trial design all matter.
What the Meta-Analyses Actually Show
The largest and most recent map of the evidence is the 2023 systematic review by Goodoory and colleagues in Gastroenterology, pooling 82 randomized controlled trials covering 10,332 IBS patients and rating each finding under the GRADE framework.
Bloating risk drops 25 percent, but certainty is low
For abdominal bloating specifically, the pooled analysis found a 25 percent lower risk of persistent bloating with probiotics versus placebo (RR 0.75, 95 percent CI 0.64 to 0.88). GRADE certainty is low to very low, due to substantial heterogeneity between studies and a high risk of bias in many underlying trials. Combination multi-strain products and Bacillus strains carried the strongest signal for bloating, while single-strain Lactobacillus and Saccharomyces products did not show a significant benefit. Global IBS symptoms dropped by 22 percent (RR 0.78, 95 percent CI 0.71 to 0.87) and abdominal pain by 28 percent (RR 0.72, 95 percent CI 0.64 to 0.82). Probiotics can help bloating on average, but certainty is low.
The Strains With the Strongest Evidence for Bloating
Several strains have dedicated placebo-controlled trial data in IBS or functional bloating. None is universally best, but the picture is clear enough to guide a real choice.
Bifidobacterium infantis (longum) 35624, the IBS gold-standard strain
The pivotal trial is the 2006 dose-finding study by Whorwell and colleagues in the American Journal of Gastroenterology, which randomized 362 women with IBS to one of three doses of B. infantis 35624 or placebo for four weeks. The 100 million CFU per day dose produced statistically significant improvements in abdominal pain, bloating, bowel-habit dissatisfaction, and overall symptom severity. Both lower (1 million) and higher (10 billion) doses failed to separate from placebo, a U-shaped dose response and a reminder that more CFU is not better. A 2005 Gastroenterology trial by O'Mahony tied the benefit to a mechanism: B. infantis 35624 normalized the IL-10 to IL-12 cytokine ratio.
Lactobacillus plantarum 299v, for pain plus bloating
A 2012 RCT by Ducrotte and colleagues in the World Journal of Gastroenterology randomized 214 IBS patients to L. plantarum 299v or placebo for four weeks. The probiotic group experienced significantly reduced abdominal pain severity and frequency (p < 0.05), and 78 percent rated efficacy as good or excellent. The Goodoory 2023 review rated L. plantarum 299v as having low-certainty evidence for global IBS symptom improvement.
Bifidobacterium lactis HN019, for transit-time-related bloating
When bloating comes with slower transit, B. lactis HN019 has a solid dose-response dataset. In a 2011 study by Waller and colleagues in the Scandinavian Journal of Gastroenterology, 100 adults received HN019 at low (1.8 billion CFU per day), high (17.2 billion CFU per day), or placebo for 14 days. The high-dose group saw whole-gut transit time fall from roughly 49 hours to about 21 hours, alongside improvements in bloating, abdominal pain, and nausea. A 2018 RCT by Ibarra and colleagues in Gut Microbes showed the strain helps adults with functional constipation, especially those with the slowest baseline bowel frequency.
Combination formulas, when two or more strains work together
Two combination products have dedicated trial data. The De Simone Formulation, an eight-strain mixture of Lactobacillus, Bifidobacterium, and Streptococcus at 450 billion CFU per dose, was tested in two Mayo Clinic RCTs: Kim 2003 found bloating significantly reduced in IBS-D patients (p = 0.046); Kim 2005 found flatulence reduced (placebo 39.5 versus probiotic 29.7, p = 0.011). The other well-evidenced combo is Lactobacillus acidophilus NCFM plus Bifidobacterium lactis Bi-07, which Ringel-Kulka and colleagues tested in a 2011 double-blind RCT in 60 patients with functional bowel disorders: bloating severity improved at both 4 weeks (p = 0.02) and 8 weeks (p < 0.01).
How Much to Take and How Long to Give It
Most positive trials for bloating used daily doses in the 100 million to 10 billion CFU range. The Whorwell 2006 data show that simply taking more is not the answer; for B. infantis 35624, 100 million CFU beat both 1 million and 10 billion. Higher-CFU products may help with other strains, but the trial-tested dose is the dose most likely to reproduce the result.
Plan on 4 to 8 weeks of consistent daily use before deciding whether a strain is helping. Most trials report first changes between weeks 2 and 4, with full benefit assessment at weeks 6 to 8. The first few days can briefly worsen gas, which usually settles within a week. If no improvement by week 4 to 6, try a different strain.
Safety and Who Should Be Cautious
For healthy adults, probiotics have a strong safety record. The Goodoory 2023 meta-analysis pooled adverse-event data from 55 trials covering more than 7,000 patients and found no significant increase in adverse events versus placebo. NCCIH flags real risks in specific populations, however: cases of severe or fatal infections have been reported in premature infants given probiotic products, and the FDA has warned providers about that risk. People with weakened immune systems, indwelling central catheters, or critical illness should talk to a clinician first. No probiotic product has FDA approval to treat any disease.
How to Choose the Best Probiotic for Bloating
Strain beats species, and trial dose beats label CFU. Look for the alphanumeric strain designation on the label (B. lactis HN019, L. plantarum 299v, B. infantis 35624, L. acidophilus NCFM), not just the genus. Match the strain to your symptom pattern: 35624 for general IBS with bloating, 299v when pain accompanies bloating, HN019 when constipation-related bloating is the issue, NCFM plus Bi-07 for functional bloating without IBS diagnosis. Give any product at least four weeks, ideally eight. Pair with fiber, hydration, and movement. Probiotics are an adjunct, not a substitute for medical evaluation when red flags appear, including unintentional weight loss, rectal bleeding, persistent severe pain, new symptoms after age 50, or a family history of GI cancer.
For daily digestive support with targeted probiotic strains, enzymes, and herbal extracts, see our Probiotic 40 Billion CFU formula and our Digestive Support blend.
Frequently Asked Questions
What is the best probiotic for bloating?
There is no single best probiotic for bloating. The strains with the strongest placebo-controlled evidence are Bifidobacterium infantis 35624 at 100 million CFU per day, Lactobacillus plantarum 299v at 10 billion CFU per day, Bifidobacterium lactis HN019 at high dose, and Lactobacillus acidophilus NCFM plus Bifidobacterium lactis Bi-07. The right choice depends on whether your bloating comes with pain, constipation, or a formal IBS diagnosis.
How long does it take for a probiotic to reduce bloating?
Most trials show measurable improvement in 4 to 8 weeks of consistent daily use. Some notice less bloating within 2 to 4 weeks; a brief gas increase in the first few days is normal. If no improvement by week 6 to 8, switch strains rather than increasing the dose of the same one.
Can probiotics make bloating worse?
Yes, in the short term. When you introduce a new strain, fermentation shifts and some people experience a temporary increase in gas or mild bloating for the first 3 to 7 days. Starting at half the label dose and stepping up reduces this effect. People with suspected SIBO may react more strongly and should work with a clinician.
Are multi-strain probiotics better than single-strain ones for bloating?
The 2023 Goodoory meta-analysis found that combination multi-strain products had a stronger signal for bloating than single-strain products. Strain identity still matters; a multi-strain blend containing strains with no trial data is not necessarily better than a well-evidenced single-strain product.
The Bottom Line
Finding the best probiotic for bloating starts with matching the strain to your symptom pattern, not with chasing the highest CFU number. B. infantis 35624 at 100 million CFU per day has the cleanest IBS evidence; L. plantarum 299v helps when pain tags along; B. lactis HN019 helps when slow transit drives distension; NCFM plus Bi-07 has solid functional bloating data. Give any of them four to eight weeks, watch for the initial gas to settle, and pair the probiotic with diet and movement. If red flags appear, talk to a clinician.
References
- Goodoory VC, Khasawneh M, Black CJ, Quigley EMM, Moayyedi P, Ford AC. Efficacy of probiotics in irritable bowel syndrome: systematic review and meta-analysis. Gastroenterology. 2023;165(5):1206-1218. https://pubmed.ncbi.nlm.nih.gov/37541528/
- Whorwell PJ, Altringer L, Morel J, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006;101(7):1581-1590. https://doi.org/10.1111/j.1572-0241.2006.00734.x
- Ducrotte P, Sawant P, Jayanthi V. Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World J Gastroenterol. 2012;18(30):4012-4018. https://doi.org/10.3748/wjg.v18.i30.4012
- Waller PA, Gopal PK, Leyer GJ, et al. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol. 2011;46(9):1057-1064. https://doi.org/10.3109/00365521.2011.584895
- Ringel-Kulka T, Palsson OS, Maier D, et al. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study. J Clin Gastroenterol. 2011;45(6):518-525. https://doi.org/10.1097/MCG.0b013e31820ca4d6
- Kim HJ, Camilleri M, McKinzie S, et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2003;17(7):895-904. https://pubmed.ncbi.nlm.nih.gov/12656692/
- O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005;128(3):541-551. https://doi.org/10.1053/j.gastro.2004.11.050
- European Society of Neurogastroenterology and Motility (ESNM) and United European Gastroenterology (UEG). European Consensus on Functional Bloating and Abdominal Distension: ESNM/UEG Recommendations for Clinical Management. United European Gastroenterol J. 2025. https://doi.org/10.1002/ueg2.70098
- National Center for Complementary and Integrative Health (NCCIH). Probiotics: What You Need to Know. National Institutes of Health, U.S. Department of Health and Human Services. https://www.nccih.nih.gov/health/probiotics-what-you-need-to-know
- Office of Dietary Supplements, National Institutes of Health. Probiotics: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Probiotics-HealthProfessional/
Disclaimer. This article is for educational purposes only and does not constitute medical advice. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before starting any new supplement, especially if you are pregnant, breastfeeding, taking medication, managing a chronic condition, immunocompromised, or treating an infant. Probiotic research is an active area, and individual responses vary by strain and person.
